Immunodominance of Lytic Cycle Antigens in Epstein-Barr Virus-Specific CD4+ T Cell Preparations for Therapy
Dinesh Adhikary, Uta Behrends, Heike Boerschmann et al. · 2007
Read Immunodominance of Lytic Cycle Antigens in Epstein-Barr Virus-Specific CD4+ T Cell Preparations for Therapy by Dinesh Adhikary, Uta Behrends, Heike Boerschmann et al. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0000583.txt.
Description
Dinesh Adhikary and colleagues prepared immune cells aimed at a lifelong virus, reporting in PLOS ONE in 2007. Epstein-Barr virus infects most people and hides in their cells for life. The team studied Epstein-Barr virus-specific CD4+ T cell preparations made for therapy. They asked which lytic cycle antigens dominate. In other words, which viral proteins do the therapeutic T cells mainly recognize?
Cell therapy grows a patient's own T cells against the virus and returns them, a strategy used when drugs fail. Knowing which antigens dominate the response tells makers whether their product aims at the right targets. Lytic antigens come from the virus's active phase, relevant when it reactivates in immune-suppressed patients.
Catalog record
| CREATOR | Dinesh Adhikary, Uta Behrends, Heike Boerschmann et al. |
|---|---|
| YEAR | 2007 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0000583